Holy Grail in Cancer Treatment? Moderna Erupts After Melanoma Vaccine Late-Stage Trial Success
(Zero Hedge)—Moderna's shares soared as much as 83% in premarket trading in New York after its personalized cancer vaccine, developed in collaboration with ...








